ReScript 12.0 has launched, marking a milestone in modernizing the language with a rewritten build system, improved ...

Billy Strings is opening up about the unexpected death of his mother, Debra Apostal, which happened in June. Strings — whose legal name is William Lee Apostal — says his mom wasn't sick leading up to ...

The average one-year price target for Replimune Group (NasdaqGS:REPL) has been revised to $10.84 / share. This is an increase of 48.75% from the prior estimate of $7.29 dated September 27, 2025. The ...

Replimune Group announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application for RP1 in combination with nivolumab, targeting advanced ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Hamza is a gaming enthusiast and a Writing Specialist from Pakistan. A firm believer in Keyboard/Mouse supremacy, he will play Tekken with WASD if you let him. He has been writing about games since ...

Singer-songwriter Billy Strings says his guitar has been his best friend for as long as he can remember. "I slept with my guitar when I was 4 or 5 years old," he says. "I'd put it right under the ...

LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group reminds investors of a class action lawsuit against Replimune Group, Inc. (“Replimune” or “the Company”) (NASDAQ: REPL) violations of §§10(b) and 20(a) ...

FARGO — Billy Strings may not exactly be a household name, but in homes tuned into bluegrass he certainly is. The 32-year-old returns to Fargo-Moorhead on Tuesday and is close to selling out the ...

Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top regulator of cancer drugs intervened during the review of the company’s lead asset ...

Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, ...